$INO

Inovio Pharmaceuticals Inc

  • NASDAQ/NGS (GLOBAL SELECT MARKET)
  • Health Technology
  • Medical Specialties
  • Manufacturing
  • Small Arms, Ordnance, and Ordnance Accessories Manufacturing

PRICE

$8.71 β–²0.694%

Last Close

VOLUME

3,168,321

DAY RANGE

8.38 - 8.73

52 WEEK

5.81 - 33.79

Join Discuss about INO with like-minded investors

profile
@viking #StockTraders.NET
recently

Upside: -CYCN +16% (announces Global Licensing agreement with Akebia Therapeutics for Praliciguat; eligible to receive up to $585M in milestone payments) -SFIX +12% (earnings, guidance) -REVG +10% (earnings, guidance) -CHS +9.9% (earnings, guidance) -EVOK +8.4% (announces FDA Orange Book Listing of U.S. Patent for Gimoti) -ASO +7.2% (earnings, guidance) -MCF +6.6% (to be acquired by Independence Energy in all stock transaction valued at ~$5.7B) -JILL +6.3% (earnings, guidance) -MRVL +5.6% (earnings, guidance) -BYSI +4.8% (announces a Late-Breaking Poster Presentation of PROTECTIVE-2 Phase 3 Data) -THO +4.1% (earnings) -STX +3.7% (raises guidance) -TSLA +2.9% (strong China May passenger vehicle sales) -INO +2.6% (expands partnership with Advaccine to conduct global Phase III efficacy trial of COVID-19 DNA vaccine candidate, INO-4800) -OTLK +2.3% (reports completion of patient dosing in the ONS-5010 Pivotal Phase 3 NORSE TWO Trial) -FTCI +1.4% (earnings, guidance; raising prices) -LUV +1.2% (guidance) Downside: -PLBY -10% (files to offer 4.0M shares) -COUP -8.9% (earnings, guidance; Tony Tiscornia promoted to CFO) -TIGR -7.6% (files to sell 6.5M ADS) -HSTO -7.5% (announces 6.0M share direct offering priced at $1.10/shr) -LESL -5.7% (to sell 24.5M shares for holders) -HQY -5.5% (earnings, guidance) -KDP -4.9% (files to sell 28M common share secondary offering on behalf of Mondelez International) -FTCI -4.7% (earnings, guidance; raising prices) -FSLY -1.7% (hearing Fastly edge CDN platform is having issues causing internet outages) -ETSY -1.3% (files proposed private offering of $1.0B of convertible senior notes) -WBA -1.3% (AMZN reportedly to offer discounted pharmacy services targeting uninsured and those paying cash)

103 Replies 9 πŸ‘ 10 πŸ”₯

ST
@StefanoC #decarolis
recently

guarda, STLA la sto seguendo proprio ora. Ho fatto ingresso fuori protocollo, per evitare scappasse via, ed ho sbagliato ovviamente. ma stiamo nei paraggi. Cmq 17,43 supportino (ino) volumetrico. Ingresso ideale per me Γ¨ attorno a 17,41. Se va piΓΉ giΓΉ credo recuperi i vuoti tra 17,266 e 17,2

99 Replies 15 πŸ‘ 11 πŸ”₯

VA
@Valckrie #StockTraders.NET
recently

INO pushing

134 Replies 7 πŸ‘ 12 πŸ”₯

BR
@brAli #StockTraders.NET
recently

ino plz bounce 7 +

110 Replies 13 πŸ‘ 15 πŸ”₯

PR
@proj8 #StockTraders.NET
recently

$INO watching if retest 6.20

82 Replies 11 πŸ‘ 7 πŸ”₯

BR
@brAli #StockTraders.NET
recently

$ino bounce tht will be a gif" onerror="this.style.display='none'" class="msg-img"/>t

135 Replies 14 πŸ‘ 8 πŸ”₯

profile
@maletone #StockTraders.NET
recently

watchlist: $SKLZ, $MVIS, $INO

95 Replies 8 πŸ‘ 13 πŸ”₯

profile
@Math #StockTraders.NET
recently

$INO back to reality

96 Replies 13 πŸ‘ 11 πŸ”₯

XX
@xX_Drip_Gawd_Xx #StockTraders.NET
recently

$INO INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today announced that it is planning for a predominantly ex-U.S. Phase 3 trial for its COVID-19 vaccine candidate, INO-4800. Given the increasing availability of vaccines authorized for emergency use, the Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) in coordination with the Office of the Assistant Secretary of Defense for Health Affairs (OASD(HA)) and the Defense Health Agency (DHA), will discontinue funding for the Phase 3 segment of the INNOVATE trial, while continuing to fund the completion of the ongoing Phase 2 segment. In correspondence, JPEO informed INOVIO: "The decision results from the changing environment of COVID-19 with the rapid deployment of vaccines. This decision is not a reflection of the awardee or product, rather a fast-moving environment associated with the former Operation Warp Speed on decisions related to future products."

89 Replies 7 πŸ‘ 11 πŸ”₯

AN
@andres168 #StockTraders.NET
recently

look at $INO

120 Replies 14 πŸ‘ 15 πŸ”₯

profile
@viking #StockTraders.NET
recently

hoping $INO get a push AH, not going to hold overnight

55 Replies 10 πŸ‘ 7 πŸ”₯

PR
@proj8 #StockTraders.NET
recently

watching $COIN $DELL $INO for short entry, $QS for a potentiial bounce

40 Replies 9 πŸ‘ 12 πŸ”₯

BR
@brAli #StockTraders.NET
recently

$btbt $INo and $MARA $RIOT $ebon $can

63 Replies 11 πŸ‘ 8 πŸ”₯

profile
@Math #StockTraders.NET
recently

$INO no dilution left under the ATMs

121 Replies 11 πŸ‘ 10 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

$INO moving...no interest as no locates

77 Replies 6 πŸ‘ 11 πŸ”₯

profile
@thegiz18 #ivtrades
recently

$INO, $NIO, $LMND, $NVAX all down after earnings

125 Replies 11 πŸ‘ 9 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$INO squeeze

138 Replies 9 πŸ‘ 6 πŸ”₯

profile
@thegiz18 #ivtrades
recently

Earnings after close today include $DDD, $CLOV, $INO, $LMND, $NIO, $OMER, $NVAX, SRPT, $ZM

141 Replies 13 πŸ‘ 6 πŸ”₯

profile
@PradeepB #droscrew
recently

70$ sold calls on FUBO and 10$ sold calls on ZYNE , 20 $ sold calls on INO

82 Replies 14 πŸ‘ 6 πŸ”₯

profile
@PradeepB #droscrew
recently

This morning I added these from my watchlist : bsqr ebon fubo pltr sens ivr MVIS and added more to my existing positions of FUBO VXRT ZYNE INO > @TkNeo said: equity not options

110 Replies 8 πŸ‘ 13 πŸ”₯

profile
@Neptune5045 #StockTraders.NET
recently

will be swinging $INO and adding pops

89 Replies 9 πŸ‘ 13 πŸ”₯

profile
@Snowcow #droscrew
recently

$fsr $mrvl $pypl $ino boss

56 Replies 14 πŸ‘ 8 πŸ”₯

profile
@Snowcow #droscrew
recently

nice $Fsr $ino $pypl

48 Replies 11 πŸ‘ 12 πŸ”₯

profile
@Snowcow #droscrew
recently

just realized $INO exploeded

59 Replies 7 πŸ‘ 8 πŸ”₯

profile
@Carlos-carvan58 #ivtrades
recently

Good morning $INO raised to $35.00

148 Replies 6 πŸ‘ 7 πŸ”₯

profile
@Snowcow #droscrew
recently

$ino getting some pm actioin

126 Replies 15 πŸ‘ 6 πŸ”₯

WI
@WINTERTRADE #StockTraders.NET
recently

wanted to trade $ino short

73 Replies 14 πŸ‘ 14 πŸ”₯

profile
@bunnytoad69 #droscrew
recently

damn $INO took a schpoop

131 Replies 15 πŸ‘ 6 πŸ”₯

profile
@dros #droscrew
recently

yeah $INO looks like it has more room. nearing a breakout

46 Replies 6 πŸ‘ 8 πŸ”₯

profile
@RohanG #droscrew
recently

@dros is it still good to enter $INO and #SNDL

91 Replies 11 πŸ‘ 15 πŸ”₯

profile
@Snowcow #droscrew
recently

I went small in $ino i just got 1 of those leaps

139 Replies 8 πŸ‘ 9 πŸ”₯

profile
@bunnytoad69 #droscrew
recently

i got enough risk on so i dont need anything, but every so often i get jealous of these juicy $INO situations

54 Replies 14 πŸ‘ 10 πŸ”₯

profile
@Snowcow #droscrew
recently

great close on $INO th

97 Replies 12 πŸ‘ 10 πŸ”₯

WI
@WINTERTRADE #StockTraders.NET
recently

hell yeah $ino

62 Replies 6 πŸ‘ 9 πŸ”₯

AN
@andres168 #StockTraders.NET
recently

INO for later in the day will be great imo

73 Replies 9 πŸ‘ 11 πŸ”₯

profile
@bunnytoad69 #droscrew
recently

$INO so fucking good ugh

100 Replies 15 πŸ‘ 15 πŸ”₯

profile
@Snowcow #droscrew
recently

$ino boom boom

140 Replies 9 πŸ‘ 10 πŸ”₯

profile
@Snowcow #droscrew
recently

$ino going for 16 again

54 Replies 11 πŸ‘ 10 πŸ”₯

profile
@dros #droscrew
recently

yeah a close over $16 on INO would be lovely

61 Replies 14 πŸ‘ 9 πŸ”₯

profile
@rg7803 #droscrew
recently

INO nice chart. Similar to TXND

134 Replies 6 πŸ‘ 6 πŸ”₯

profile
@Snowcow #droscrew
recently

wow $ino is running hard

63 Replies 10 πŸ‘ 8 πŸ”₯

profile
@Snowcow #droscrew
recently

I got $ino when dros mentioned it

70 Replies 8 πŸ‘ 6 πŸ”₯

profile
@dros #droscrew
recently

1311 $INO JAN2023 $5 Cs bought 10.2

133 Replies 12 πŸ‘ 7 πŸ”₯

profile
@dros #droscrew
recently

1311 $INO JAN2023 $5 Cs bought 10.2

130 Replies 11 πŸ‘ 15 πŸ”₯

profile
@Carlos-carvan58 #ivtrades
recently

1,023 $INO 100 (Weeklys) 5 FEB 21 16 CALL @.74 LMT

106 Replies 13 πŸ‘ 10 πŸ”₯

profile
@maletone #StockTraders.NET
recently

wonder when $INO will be back under $6

100 Replies 11 πŸ‘ 13 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$INO doing offerings

97 Replies 11 πŸ‘ 11 πŸ”₯

profile
@dros #droscrew
recently

$INO (+4.9% pre) INOVIO and Advaccine Announce Exclusive Partnership To Commercialize COVID-19 DNA Vaccine Candidate, INO-4800, in Greater China - SI

87 Replies 7 πŸ‘ 12 πŸ”₯

profile
@viking #StockTraders.NET
recently

$INO straight back from where it came from this morn. real clean

117 Replies 14 πŸ‘ 8 πŸ”₯

profile
@viking #StockTraders.NET
recently

$INO up on vaccine news? bit late to the game arent they?

141 Replies 7 πŸ‘ 10 πŸ”₯

Key Metrics

Market Cap

1.82 B

Beta

0.44

Avg. Volume

5.58 M

Shares Outstanding

209.40 M

Yield

0%

Public Float

0

Next Earnings Date

2021-08-09

Next Dividend Date

Company Information

INOVIO is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with HPV. INOVIO is the first and only company to have clinically demonstrated that a DNA medicine can be delivered directly into cells in the body via a proprietary smart device to produce a robust and tolerable immune response. INOVIO's lead immunotherapy candidate, VGX-3100, currently in Phase 3 trials for precancerous cervical dysplasia, cleared high-risk HPV-16 and/or HPV-18 in a Phase 2b clinical trial. High-risk HPV is responsible for 70% of cervical cancer, 91% of anal cancer, and 69% of vulvar cancer. Also in development are programs targeting HPV-related cancers and a rare HPV-related disease, recurrent respiratory papillomatosis (RRP); non-HPV-related cancers glioblastoma multiforme (GBM) and prostate cancer; as well as infectious disease DNA vaccine development programs in coronaviruses associated with COVID-19 diseases and MERS, Lassa fever, Ebola, and HIV. Partners and collaborators include Advaccine, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA)/Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND)/Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute (IVI), Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron, Richter-Helm BioLogics, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. INOVIO also is a proud recipient of 2020 Women on Boards 'W' designation recognizing companies with more than 20% women on their board of directors.

CEO: Jong Kim

Website:

HQ: 6769 Mesa Ridge Rd San Diego, 92121-2995 California

Related News

  • Stock Equity

    Traders shouldnt Staggering on this: Inovio Pharmaceuticals, Inc. (NASDAQ:INO), HUYA Inc. (NYSE:HUYA)

    22 Jun 2021, 20:48
  • InvestorPlace

    Inovio Pharmaceuticals Could See a Boost from Covid-19 Partnerships

    21 Jun 2021, 20:51
  • Stock Equity

    Featured Volatile Stock- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) encountered the change of -3.74%

    20 Jun 2021, 22:24
  • MarketWatch

    Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors

    18 Jun 2021, 22:43
  • Stock Equity

    Analysts Suggestions in the Limelight: Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Gerdau S.A. (NYSE:GGB)

    18 Jun 2021, 21:51